Society Insider: Wilhelmina and Ben O’Keeffe launch longevity and wellness clinic in Auckland
Ben, who studied ophthalmology in Wellington after university, moved to Auckland three years ago to be with Wilhelmina,…
Cross-border health issues highlighted after NSW patient claims they were refused care by ACT hospital
The cross-border healthcare system between the ACT and NSW is under scrutiny after a Googong resident claimed they…
Global analysis of country-level factors associated with chatbot usage for health
We organize our results around the two dependent variables: (1) the share of AI conversations devoted to health…
EMA and EISMEA boost cooperation to accelerate health innovations
EMA and the European Innovation Council and SMEs Executive Agency (EISMEA) have strengthened their cooperation in support of…
This healthcare stock just jumped 15% and experts are tipping a further 80% rise
ASX healthcare stock EMvision Medical Devices Ltd (ASX: EMV) could be a growth stock about to take off,…
Your smartwatch might be making your sleep worse
An Apple Watch Series 11 is displayed at an Apple Store in September 2025. Wearables and sleep-tracking devices…
Goldman Sachs Says the Crowd Is Wrong on This Beaten-Down Medical Robotics Giant
Intuitive Surgical (ISRG +2.47%) has faced challenges over the past 12 months, and its shares have declined by…
Subscribe to The Australian | Newspaper home delivery, website, iPad, iPhone & Android apps
The Australian Digital 12 Month Plan costs $416 (min. cost) for the first 12 months, charged as $32…
Septa Pharmaceuticals Inc. Acquires CeeNU® (Lomustine) from Bristol Myers Squibb, Canada
Mississauga, ON, July 15, 2026 /PRNewswire/ – Septa Pharmaceuticals Inc., a rapidly growing leader in the Canadian healthcare…
A genetic window on ‘All of Us’ — Harvard Gazette
Just as this country celebrated its 250th birthday, some geneticists were celebrating America, too. At the end of…
FDA drug approval affects healthcare around the world, but political shortcuts could hurt the agency’s international reputation
At the beginning of July 2026, the U.S. Food and Drug Administration approved the first gene therapy for…
Health insurance stocks slide after Elevance highlights margin pressures (ELV)
Male doctor with patient ©Adobe Stock Images Health insurance shares moved sharply lower in premarket trading after Elevance…